# Prospective, Post-registration, Interventional, Randomized, in Parallel Groups, Multicenter Eurasian Clinical Study of DERIVO®/DERIVO® Mini Aneurysm Embolization Device, Europe-Asia

Study · id `cardio:ct-nct06400940` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06400940](<https://clinicaltrials.gov/study/NCT06400940>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06400940

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 640 participants.

## Technical summary

Registry record NCT06400940. Randomized; no masking; primary purpose treatment. Start 2023-08-17 (actual); primary completion 2026-08-17 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 640 participants (planned count; ClinicalTrials.gov record NCT06400940, source copy `cardio:ctgov-nct06400940-2024-05-06`, retrieved 2026-11-18)
- Started: 2023-08-17 (actual) (ClinicalTrials.gov record NCT06400940, source copy `cardio:ctgov-nct06400940-2024-05-06`, retrieved 2026-11-18)
- Primary completion: 2026-08-17 (anticipated) (ClinicalTrials.gov record NCT06400940, source copy `cardio:ctgov-nct06400940-2024-05-06`, retrieved 2026-11-18)
- Completion: 2028-08 (anticipated) (ClinicalTrials.gov record NCT06400940, source copy `cardio:ctgov-nct06400940-2024-05-06`, retrieved 2026-11-18)
- Countries: Russia (ClinicalTrials.gov record NCT06400940, source copy `cardio:ctgov-nct06400940-2024-05-06`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06400940-2024-05-06`, retrieved 2026-11-18)

## The registry's words

- Brief title: Prospective, Post-registration, Interventional, Randomized, in Parallel Groups, Multicenter Eurasian Clinical Study of DERIVO®/DERIVO® Mini Aneurysm Embolization Device, Europe-Asia
- Condition: Intracranial Aneurysm
- Intervention (Drug): ticagrelor (tablets, 180 mg) or prasugrel (tablets, 10 mg).
- Intervention (Drug): combination of clopidogrel (tablets, 75 mg) and acetylsalicylic acid (ASA, tablets, 100 mg) or a combination of ticagrelor (tablets, 180 mg) and ASA (tablets, 100 mg).
- Lead sponsor: Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Brain aneurysm (intracranial aneurysm) (`cardio:intracranial-aneurysm`)

## Provenance

Content hash: d438b0a1c4c603b3d7ff4b1c8f9073b4d6ced5fc9f7a4bb43c1ad5d22786cc61
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
